86 related articles for article (PubMed ID: 6420597)
1. Differentiation and tumorigenicity of human malignant melanocytes in relation to their culture conditions.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1984 Jan; 72(1):3-12. PubMed ID: 6420597
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
[TBL] [Abstract][Full Text] [Related]
3. [Differentiation and tumorigenicity of human malignant melanocytes. Comparative study of two "non pigmented" and pigmented lines from the same fibroblastoid cells].
Aubert C; Rougé F; Galindo JR
C R Seances Acad Sci D; 1979 Mar; 288(10):919-22. PubMed ID: 111834
[TBL] [Abstract][Full Text] [Related]
4. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between differentiation and malignancy in human malignant melanocytes "in vivo" and "in vitro" (author's transl)].
Foa C
Bull Cancer; 1979; 66(3):235-58. PubMed ID: 114247
[TBL] [Abstract][Full Text] [Related]
6. Ultrastruct and biochemical chantes in cultured human malignant melanoma cells after heterotransplantation into nude mice.
Aubert C; Chirieceanu E; Foa C; Rorsman H; Rosengren E; Rougé F
Cancer Res; 1976 Sep; 36(9 pt.1):3106-12. PubMed ID: 975076
[TBL] [Abstract][Full Text] [Related]
7. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
Kerbel RS; Man MS; Dexter D
J Natl Cancer Inst; 1984 Jan; 72(1):93-108. PubMed ID: 6582307
[TBL] [Abstract][Full Text] [Related]
8. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
[TBL] [Abstract][Full Text] [Related]
9. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
[TBL] [Abstract][Full Text] [Related]
10. Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.
Glovanella BC; Stehlin JS; Santamaria C; Yim SO; Morgan AC; Williams LJ; Leibovitz A; Fialkow PJ; Mumford DM
J Natl Cancer Inst; 1976 Jun; 56(6):1131-42. PubMed ID: 994214
[TBL] [Abstract][Full Text] [Related]
11. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
[TBL] [Abstract][Full Text] [Related]
12. [Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)].
Morishima T; Saito M; Fujita M; Fukada E; Nagashima N; Hanawa S
Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(2):157-9. PubMed ID: 6806514
[No Abstract] [Full Text] [Related]
13. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation of an achromatic metastatic human melanoma. Development in vitro and tumorigenicity in nude mice].
Aubert C; Rougé F
C R Acad Hebd Seances Acad Sci D; 1978 Jan; 286(1):165-8. PubMed ID: 417854
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice.
Cornil I; Man S; Fernandez B; Kerbel RS
J Natl Cancer Inst; 1989 Jun; 81(12):938-44. PubMed ID: 2733038
[TBL] [Abstract][Full Text] [Related]
17. Growth of human melanoma in nude mice: suppression by T-lymphocytes from the tumor donor: brief communication.
Coates AS; Crawford M
J Natl Cancer Inst; 1977 Oct; 59(4):1325-9. PubMed ID: 302865
[TBL] [Abstract][Full Text] [Related]
18. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Fodstad O; Kjønniksen I; Aamdal S; Nesland JM; Boyd MR; Pihl A
Cancer Res; 1988 Aug; 48(15):4382-8. PubMed ID: 3390834
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
20. 5-S-cysteinyldopa in diagnosis and treatment of human malignant melanomas and ultrastructural observations.
Aubert C; Rosengren E; Rorsman H; Rouge F; Foa C; Lipcey C
Eur J Cancer (1965); 1977 Nov; 13(11):1299-308. PubMed ID: 590287
[No Abstract] [Full Text] [Related]
[Next] [New Search]